Abate Kristin bought KPTI
February 28, 2025 · Form 4 insider transaction
Abate Kristin bought 1,866 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,866
Price
$0.00
Total value
N/A
InsiderAbate Kristin
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2025
Filing dateMarch 4, 2025
Shares owned after1,866
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025.; This option was granted on February 28, 2025 pursuant to the 2022 Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.